SCHEMBL16620422

SCHEMBL16620422

CCN1CCN(Cc2ccc(NC(=O)C(F)(F)F)cc2Cl)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.54
NR1H4 Q96RI1 1/20 0.54
CYP2D6 P10635 3/20 0.52
MEN1 O00255 1/20 0.52
CYP2C19 P33261 1/20 0.52
KMT2A Q03164 1/20 0.52
NPY2R P49146 3/20 0.52
CHRM1 P11229 6/20 0.51
CHRM4 P08173 3/20 0.51
RET P07949 3/20 0.50
KDR P35968 2/20 0.50
CHRM5 P08912 3/20 0.49
CHRM3 P20309 3/20 0.49
NPC1 O15118 2/20 0.48
TP53 P04637 2/20 0.48
RAB9A P51151 2/20 0.48
CYP2C9 P11712 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
POLB P06746 1/20 0.48
CHRM2 P08172 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3182950 0.86 RET (0.63) RETKDR
SCHEMBL16620022 0.85 CYP2D6 (0.56) CYP2D6MEN1CYP2C19KMT2ACHRM1
SCHEMBL16629103 0.77 POLB (0.55) CYP2D6MEN1CYP2C19KMT2ACHRM1
SCHEMBL16620032 0.77 EPHX2 (0.57) EPHX2NR1H4MEN1CYP2C19KMT2A
SCHEMBL22060074 0.77 EPHX2 (0.66) EPHX2NR1H4MEN1CYP2C19KMT2A
SCHEMBL4933270 0.76 KIT (0.65) RET
SCHEMBL16587846 0.75 RET (0.68) RETKDR
SCHEMBL16620122 0.75 EPHX2 (0.57) EPHX2NR1H4MEN1CYP2C19KMT2A
SCHEMBL25292715 0.75 ABL1 (0.57) NPY2RTP53POLB
SCHEMBL16620534 0.75 KDM4E (0.48) EPHX2MEN1CYP2C19KMT2ANPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
US-20150045255-A1 Endometrial Phase or Endometrial Cancer Biomarkers WALFISH, PAUL (CA) 2015-02-12 US disclosed